Group Wants FDA to Review More Drug Ads
32413
WASHINGTON -- Regulators are issuing fewer citations to drug companies for false and misleading advertisements and are taking longer to do it, a congressional report says.
732137
U.S. health officials said on Friday they would review whether to take regulatory action over Merck & Co Inc and Schering-Plough's cholesterol medicine Vytorin following the drug's failure to work better than a generic drug in a study of plaque build-up in neck arteries.
682721
Biotech companies, medical device  makers and food manufacturers joined patient groups and three  former U.S. health secretaries on Monday in calling for  increased funding for the Food and Drug Administration.
165206
_The Food and Drug Administration is advising women who recently received mammograms at Ecumed Health Group in Hialeah, Fla., to seek another screening or an independent review of past film to ensure breast cancer warnings weren&#39;t missed.
29024
A campaign is launched to get members of the public to report any side-effects from medicines.
223061
Drug companies could soon make more experimental drugs available for a fee to more patients with serious or life-threatening diseases that have no approved treatments, under revised rules the U.S. Food and Drug Administration proposed on Monday.
513761
The U.S. Food and Drug Administration on Friday asked an outside group to review the way it monitors safety risks associated with medicines already on the market, such as Merck & Co. Inc.'s withdrawn painkiller Vioxx.
55690
U.S. regulators said on Friday they would review whether to take action over Merck & Co Inc's  and Schering-Plough Corp's  popular cholesterol medicine Vytorin after a study showed it was no better than a generic drug in preventing the build-up of fatty plaque.
765930
U.S. regulators said on Friday they  would review a study showing a Merck and Schering-Plough  cholesterol drug worked no better than a generic in preventing  the build-up of arterial plaque.
185982
The editors of the Journal of the American Medical Association (JAMA) are calling for an end to the US Food and Drug Administration&#39;s (FDA) role in post-market monitoring of the safety of drugs it approves.
280625
U.S. regulators said on Friday they would review whether to take action over Merck & Co Inc's and Schering-Plough Corp's popular cholesterol medicine Vytorin after a study showed it was no better than a generic drug in preventing the build-up of fatty plaque.
121562
Almost one-fifth of the Food and Drug Administration scientists surveyed two years ago as part of an official review said they had been pressured to recommend approval of a new
237882
The Public Citizen Health Research Group is petitioning the Food and Drug Administration to increase the warnings on the popular cosmetic and drug Botox.
458929
U.S. health officials said on Friday  they would review whether to take regulatory action over Merck  & Co Inc and Schering-Plough's cholesterol medicine Vytorin  following the drug's failure to work better than a generic drug  in a study of plaque build-up in neck arteries.
432727
A congressional subcommittee wants to subpoena criminal investigators at the Food and Drug Administration about their own probe concerning the antibiotic Ketek, which has been linked to liver failure.
518488
The US regulator to beef up monitoring of drug safety after criticism over a painkiller linked to heart disease.
319518
WASHINGTON &#151; Safety concerns about a GlaxoSmithKline diabetes drug prompted some Democratic lawmakers on Wednesday to rebuke the Food and Drug Administration and call for increased regulation of the pharmaceutical industry.